Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 6/20 | 0.54 |
| ▸ | CES1 | P23141 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | LPAR1 | Q92633 | 7/20 | 0.50 |
| ▸ | FABP3 | P05413 | 5/20 | 0.50 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.50 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.50 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.50 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.50 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.50 |
| ▸ | CES2 | O00748 | 1/20 | 0.50 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.50 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3792251 | 1.00 | FAAH (0.54) | FAAHCES1MEN1TP53CYP1A2 | |
| SCHEMBL25868 | 0.91 | FAAH (0.46) | FAAHCES1MEN1CYP1A2KMT2A | |
| SCHEMBL2782415 | 0.91 | FAAH (0.46) | FAAHCES1MEN1CYP1A2KMT2A | |
| SCHEMBL2783090 | 0.91 | FAAH (0.46) | FAAHCES1MEN1CYP1A2KMT2A | |
| SCHEMBL1417477 | 0.78 | FAAH (0.58) | FAAHCES1MEN1TP53CYP1A2 | |
| SCHEMBL6510863 | 0.78 | LPAR3 (0.47) | FAAHMEN1TP53CYP1A2CYP3A4 | |
| SCHEMBL28857015 | 0.78 | FAAH (0.58) | FAAHCES1MEN1TP53CYP1A2 | |
| SCHEMBL466646 | 0.77 | FAAH (0.51) | FAAHCES1MEN1TP53CYP1A2 | |
| SCHEMBL466851 | 0.77 | FAAH (0.51) | FAAHCES1MEN1TP53CYP1A2 | |
| SCHEMBL466712 | 0.77 | FAAH (0.51) | FAAHCES1MEN1TP53CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250017856-A1 | CO-FORMULATION AND CO-DELIVERY OF IONIZABLE COLLOID FORMING DRUGS WITH NUCLEIC ACIDS | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2025-01-16 | — | — | US | claimed |
| US-12083223-B2 | Nanolipoprotein particles and related compositions methods and systems for loading RNA | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC (US) | 2024-09-10 | — | — | US | claimed |
| US-20240207186-A1 | NANOLIPOPROTEIN PARTICLES AND RELATED COMPOSITIONS METHODS AND SYSTEMS FOR LOADING RNA | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2024-06-27 | — | — | US | claimed |
| EP-3646883-B1 | NOVEL TUMOR VACCINE AND USE THEREOF | WESTVAC BIOPHARMA CO LTD (CN) | 2023-10-18 | — | — | EP | claimed |
| US-20180318218-A1 | NANOLIPOPROTEIN PARTICLES AND RELATED COMPOSITIONS METHODS AND SYSTEMS FOR LOADING RNA | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2018-11-08 | — | — | US | claimed |
| WO-2018204495-A1 | NANOLIPOPROTEIN PARTICLES AND RELATED COMPOSITIONS METHODS AND SYSTEMS FOR LOADING RNA | SYNTHETIC GENOMICS, INC. (US) | 2018-11-08 | — | — | WO | claimed |
| US-9944676-B2 | Cationic lipid formulations for regressing established tumor | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2018-04-17 | — | — | US | claimed |
| US-20170267719-A1 | METHOD FOR REGRESSING PANCREATIC TUMOR BY A LIPOSOMAL FORMULATION ALONG WITH DNA VACCINES | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2017-09-21 | — | — | US | claimed |
| US-20160304558-A1 | CATIONIC LIPID FORMULATIONS FOR REGRESSING ESTABLISHED TUMOR | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2016-10-20 | — | — | US | claimed |
| US-20150132369-A1 | NANOLIPOSOMAL CYCLOSORIN FORMULATIONS FOR IMMUNOSUPPRESION AND METHODS FOR THE PRODUCTION THEREOF | Exir Nano Sina Company (IR) | 2015-05-14 | — | — | US | claimed |
| WO-2009031911-A1 | CATIONIC LIPOSOME CARRIER FOR GENETIC DRUGS | UNIWERSYTET WROCLAWSKI (PL) | 2009-03-12 | — | — | WO | claimed |
| EP-4724485-A1 | BACKPACKED-ANTIBODY CONSTRUCTS AND THEIR USES | Universidad del País Vasco/Euskal Herriko Unibertsitatea (ES) | 2026-04-15 | — | — | EP | disclosed |
| US-20260049154-A1 | IMMUNO-NANOPARTICLES, AND RELATED CELLS, COMPOSITIONS, METHODS AND SYSTEMS | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2026-02-19 | — | — | US | disclosed |
| EP-4687853-A1 | LIPID NANOPARTICLE COMPOSITIONS | Københavns Universitet (DK) | 2026-02-11 | — | — | EP | disclosed |
| US-20250382341-A1 | METHODS AND COMPOSITIONS OF IN VIVO ENGINEERING OF T-CELLS TO ANTI-INFLAMMATORY CELLS AND THERAPEUTIC APPLICATIONS THERE OF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-12-18 | — | — | US | disclosed |
| WO-2008141230-A1 | METHODS AND SYSTEMS FOR MONITORING PRODUCTION OF A TARGET PROTEIN IN A NANOLIPOPROTEIN PARTICLE | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC (US) | 2008-11-20 | — | — | WO | disclosed |
| US-20080213774-A1 | Mutations in Kit Confer Imatinib Resistance in Gastrointestinal Stromal Tumors | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2008-09-04 | — | — | US | disclosed |
| US-7329495-B2 | Mutations in KIT confer imatinib resistance in gastrointestinal stromal tumors | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2008-02-12 | — | — | US | disclosed |
| US-20060019280-A1 | Determining the presence of a T->C mutation at nucleotide position 1982 of the KIT gene, in a sample obtained from the cancer | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2006-01-26 | — | — | US | disclosed |
| US-20040101901-A1 | Novel lipophilic complexes for insertion of receptors into lipid membranes | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2004-05-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12083223-B2 | Nanolipoprotein particles and related compositions methods and systems for loading RNA | SARNP, SYNCRIP, AUP1 | FAAH 2557/4885CES1 1545/4885MEN1 2818/4885 |
| US-20260049154-A1 | IMMUNO-NANOPARTICLES, AND RELATED CELLS, COMPOSITIONS, METHODS AND SYSTEMS | CD274, LY96, ICOS | FAAH 1845/4885CES1 1553/4885MEN1 4204/4885 |
| US-20170267719-A1 | METHOD FOR REGRESSING PANCREATIC TUMOR BY A LIPOSOMAL FORMULATION ALONG WITH DNA VACCINES | PLEC, APLNR, CMKLR1 | FAAH 4567/4885CES1 3146/4885MEN1 13/4885 |
| US-20160304558-A1 | CATIONIC LIPID FORMULATIONS FOR REGRESSING ESTABLISHED TUMOR | CMKLR2, CMKLR1, LPAR2 | FAAH 3303/4885CES1 2584/4885MEN1 2930/4885 |
| US-20250382341-A1 | METHODS AND COMPOSITIONS OF IN VIVO ENGINEERING OF T-CELLS TO ANTI-INFLAMMATORY CELLS AND THERAPEUTIC APPLICATIONS THERE OF | NFATC1, NSUN3, NSUN2 | FAAH 4475/4885CES1 2573/4885MEN1 4794/4885 |
| US-20240207186-A1 | NANOLIPOPROTEIN PARTICLES AND RELATED COMPOSITIONS METHODS AND SYSTEMS FOR LOADING RNA | SARNP, SYNCRIP, AUP1 | FAAH 2557/4885CES1 1545/4885MEN1 2818/4885 |
| US-20180318218-A1 | NANOLIPOPROTEIN PARTICLES AND RELATED COMPOSITIONS METHODS AND SYSTEMS FOR LOADING RNA | SARNP, SYNCRIP, AUP1 | FAAH 2557/4885CES1 1545/4885MEN1 2818/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.